In about 2/3 of the cases studied (152 patients), the combination of deprenyl and the substitution-therapy has a favourable effect as it tends to normalize motor activity. Although the administering of deprenyl renders neither L-Dopa nor the decarboxylase inhibitor superfluous, their side effects can be slightly reduced as their dose is reduced. Therefore it is advised to give all patients a trial with this drug.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/BF01246963 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Concomitant use of monoamine oxidase inhibitor and tyrosine in parenteral nutrition.
Eur J Clin Nutr
March 2024
Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA.
Monoamine oxidase inhibitors (MAOIs) prevent the breakdown of tyramine in the body, and can cause a sudden increase in blood pressure with significant tyramine build up. This phenomenon, when it occurs, is known as tyramine pressor response. It is unknown if tyrosine administered in parenteral nutrition (PN) leads to tyramine build-up with concomitant use of MAOIs.
View Article and Find Full Text PDFVisualization of painful inflammation in patients with pain after traumatic ankle sprain using [C]-D-deprenyl PET/CT.
Scand J Pain
October 2017
Department of Anesthesiology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Background And Aims: Positron emission tomography (PET) with the radioligand [C]-D-deprenyl has shown increased signal at location of pain in patients with rheumatoid arthritis and chronic whiplash injury. The binding site of [C]-D-deprenyl in peripheral tissues is suggested to be mitochondrial monoamine oxidase in cells engaged in post-traumatic inflammation and tissue repair processes. The association between [C]-D-deprenyl uptake and the transition from acute to chronic pain remain unknown.
View Article and Find Full Text PDFA prospective study of freezing of gait with early Parkinson disease in Chinese patients.
Medicine (Baltimore)
June 2016
aDepartment of Neurology bDepartment of Psychiatry, Third People's Hospital of Huzhou cDepartment of Neurology, Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang Province, China.
This study investigated the risk factors for freezing of gait (FOG) in the early stage of Parkinson disease in China, using a sample of 248 patients who were followed for 3 years. Part III of the Unified Parkinson Disease Rating Scale and the modified Hoehn-Yahr grading scale were used to evaluate the severity of motor symptoms. Nonmotor symptoms were assessed using the Hamilton Anxiety Rating Scale, Hamilton Depression Rating Scale (HAMD), and Non-Motor Symptoms Scale (NMSS).
View Article and Find Full Text PDFCritical appraisal of selegiline transdermal system for major depressive disorder.
Expert Opin Drug Deliv
September 2016
a The Mood and Anxiety Disorders Treatment and Research Program, Department of Psychiatry, Perelman School of Medicine , University of Pennsylvania, Philadelphia , PA , USA.
Introduction: Although safer and easier to use antidepressants (ie.,SSRIs/SNRIs) have largely displaced MAOIs, these medications still have a role in difficult to treat conditions. Efforts to improve MAOIs benefit-risk profile resulted on the reversible MAOI and in the first antidepressant patch (selegiline transdermal delivery system-STS).
View Article and Find Full Text PDFPredicting placebo response in adolescents with major depressive disorder: The Adolescent Placebo Impact Composite Score (APICS).
J Psychiatr Res
September 2015
Department of Psychiatry, University of Texas Southwestern Medical Center, USA; Children's Medical Center of Dallas, USA.
Objective: The aim of this study was to construct a composite scoring system to predict the probability of placebo response in adolescents with Major Depressive Disorder (MDD).
Method: Participants of the current study were 151 adolescents (aged 12-17 years) who were randomized to the placebo arm (placebo transdermal patches) of a randomized controlled trial (RCT) comparing the selegiline transdermal patch with placebo (DelBello et al., 2014).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!